Search Results - "KEANE, W. F"

Prevention of diabetic renal disease with special reference to microalbuminuria by Mogensen, C E, Keane, W F, Bennett, P H, Jerums, G, Parving, H H, Passa, P, Steffes, M W, Striker, G E, Viberti, G C

Get more information

Lipids and the kidney by Keane, William F.

Get full text

Adult peritoneal dialysis-related peritonitis treatment recommendations : 2000 UPDATE by KEANE, William F, BAILIE, George R, BOESCHOTEN, Elizabeth, GOKAL, Ram, GOLPER, Thomas A, HOLMES, Clifford J, KAWAGUCHI, Yoshindo, PIRAINO, Beth, RIELLA, Miguel, VAS, Stephen

Get full text

Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): A position paper of the National Kidney Foundation by Keane, William F., Eknoyan, Garabed

Get full text

Lovastatin inhibits proliferation of rat mesangial cells by O'DONNELL, M. P, KASISKE, B. L, KIM, Y, ATLURU, D, KEANE, W. F

“…Products of intracellular mevalonate metabolism are essential for cell growth and proliferation. Lovastatin, an inhibitor of 3-hydroxy-3-methylglutaryl…”
Get full text

Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats by Kasiske, Bertram L., O'donnell, Michael P., Cleary, Margot P., Keane, William F.

“…Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Hyperlipidemic obese Zucker rats develop albuminuria and spontaneous focal…”
Get full text

Pharmacologic Treatment of Hyperlipidemia Reduces Glomerular Injury in Rat 5/6 Nephrectomy Model of Chronic Renal Failure by Kasiske, Bertram L, OʼDonnell, Michael P, Garvis, William J, Keane, William F

“…The role of lipid abnormalities in the pathogenesis of focal glomerulosclerosis was investigated in the rat remnant kidney model of chronic renal failure. Rats…”
Get full text

Inhibition of the mevalonate pathway: benefits beyond cholesterol reduction? by Massy, Z A, Keane, W F, Kasiske, B L

Get more information

Lipid abnormalities in end stage renal disease by ODA, H, KEANE, W. F

Get full text

Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysis by Keane, W F, Collins, A J

“…It has been established that mortality among US end-stage renal disease patients is higher than in many other developed countries. The explanation for this…”
Get more information

Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update by Keane, W F, Alexander, S R, Bailie, G R, Boeschoten, E, Gokal, R, Golper, T A, Holmes, C J, Huang, C C, Kawaguchi, Y, Piraino, B, Riella, M, Schaefer, F, Vas, S

“…The recommendations provided in this document represent a distillation of various experiences, as well as data obtained from published studies in the setting…”
Get more information

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy by Brenner, Barry M, Cooper, Mark E, de Zeeuw, Dick, Keane, William F, Mitch, William E, Parving, Hans-Henrik, Remuzzi, Giuseppe, Snapinn, Steven M, Zhang, Zhonxin, Shahinfar, Shahnaz

“…Angiotensin-receptor blockade may delay the onset of end-stage renal disease and ameliorate heart failure in patients with type 2 diabetes. Interruption of the…”
Get full text

Angiotensin converting enzyme inhibitors and progressive renal insufficiency. Current experience and future directions by Keane, W F, Anderson, S, Aurell, M, de Zeeuw, D, Narins, R G, Povar, G

“…To review the rationale for using angiotensin converting enzyme (ACE) inhibitors in progressive renal disease, and to evaluate the experience with these agents…”
Get more information

The Zucker Rat Model of Obesity, Insulin Resistance, Hyperlipidemia, and Renal Injury by Kasiske, Bertram L, OʼDonnell, Michael P, Keane, William F

“…Although the pathogenesis of obesity in OZR is unknown, the association among hyperinsulinemia, insulin resistance, and hyperlipidemia suggests that…”
Get full text

Rabeprazole: Pharmacokinetics and Tolerability in Patients with Stable, End-Stage Renal Failure by Keane, William F., Swan, Suzanne K., Grimes, Imogene, Humphries, Thomas J.

“…The authors compare the pharmacokinetic profiles, safety, and tolerability of rabeprazole, a new proton pump inhibitor (PPI), in healthy volunteers and in…”
Get full text

Lipids and progressive renal disease: The cardio-renal link by Keane, William F.

Get full text

Disposition of gabapentin in anuric subjects on hemodialysis by Wong, M O, Eldon, M A, Keane, W F, Türck, D, Bockbrader, H N, Underwood, B A, Sedman, A J, Halstenson, C E

“…Gabapentin is an anticonvulsant drug, which in man is cleared solely by renal excretion and is not bound to plasma proteins. Because the clearance of…”
Get more information

Opioid-mediated suppression of interferon-γ production by cultured peripheral blood mononuclear cells by PETERSON, P. K, SHARP, B, GEKKER, G, BRUMMITT, C, KEANE, W. F

“…Mounting evidence suggests that opiate addiction and stress are associated with impaired cell-mediated immunity. We tested the hypothesis that morphine and the…”
Get full text

Lipids and progressive glomerulosclerosis. A model analogous to atherosclerosis by Keane, W F, Kasiske, B L, O'Donnell, M P

Get more information

Pharmacokinetics of vancomycin in patients with various degrees of renal function by MATZKE, G. R, MCGORY, R. W, HALSTENSON, C. E, KEANE, W. F

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text